mitomycin has been researched along with mycophenolic acid in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Buron, F; Héquet, O; Malcus, C; Morelon, E; Moulin, FT; Perrin, H | 1 |
Amer, R; Levi-Schaffer, F; Maftsir, G; Puxeddu, I; Rabinowich, L; Solomon, A | 1 |
Birnbaum, F; Böhringer, D; Eberwein, P; Reinhard, T; Schwartzkopff, J | 1 |
Cheng, X; Han, P; Ruan, J; Sun, D; Sun, S; Zhang, Y | 1 |
1 review(s) available for mitomycin and mycophenolic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
6 other study(ies) available for mitomycin and mycophenolic acid
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Mesenchymal stem cell and immunosuppressive drug interactions.
Topics: Cell Division; Cyclosporine; Drug Interactions; Humans; Immunosuppressive Agents; Mesenchymal Stem Cells; Mitomycin; Mycophenolic Acid; Sirolimus | 2009 |
Mycophenolic acid suppresses human pterygium and normal tenon fibroblast proliferation in vitro.
Topics: Adult; Aged; Analysis of Variance; Apoptosis; Cell Proliferation; Cells, Cultured; Dexamethasone; Dose-Response Relationship, Drug; Fibroblast Growth Factor 2; Fibroblasts; Humans; Middle Aged; Mitomycin; Mycophenolic Acid; Pterygium; Strabismus | 2010 |
Allogenic limbo-keratoplasty with conjunctivoplasty, mitomycin C, and amniotic membrane for bilateral limbal stem cell deficiency.
Topics: Adult; Alkylating Agents; Amnion; Conjunctiva; Corneal Diseases; Cyclosporine; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Keratoplasty, Penetrating; Limbus Corneae; Male; Middle Aged; Mitomycin; Mycophenolic Acid; Retrospective Studies; Stem Cells; Transplantation, Homologous; Visual Acuity | 2012 |
Mitomycin, 5-fluorouracil, leflunomide, and mycophenolic acid directly promote hepatitis B virus replication and expression in vitro.
Topics: Antineoplastic Agents; Fluorouracil; Hep G2 Cells; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunosuppressive Agents; Leflunomide; Mitomycin; Mycophenolic Acid; Reinfection; Virus Replication | 2020 |